Definium Therapeutics Inc. Common Shares vs nVent Electric — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while nVent Electric trades at $166.3 (market cap $27.16B). The key difference: nVent Electric is far larger — about 5.8× Definium Therapeutics Inc. Common Shares's market cap, and nVent Electric pays a 0.5% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and nVent Electric for 11 Days on average.
| DFTX | NVT | |
|---|---|---|
Market Cap | $4.71B | $27.16B |
Volume | 1,966,636 | 1,530,782 |
Sector | Health | Industrials |
52-Week High | $48.45 | $184.34 |
52-Week Low | $10.68 | $94.99 |
Typical Hold Time | 0 Days | 11 Days |
Enterprise Value | $3.67B | $28.54B |
Dividend Yield | — | 0.5% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →nVent provides electrical connection and protection solutions, including enclosures, fastening systems, and thermal management products. Its products help support electrical and industrial infrastructure across multiple end markets.
Read more on NVT →